Literature DB >> 29360466

Enteric nervous system manifestations of neurodegenerative disease.

Alcmène Chalazonitis1, Meenakshi Rao2.   

Abstract

Neurological disorders cause gastrointestinal (GI) symptoms that are debilitating and markedly diminish quality of life in patients. The enteric nervous system (ENS), the intrinsic nervous system of the GI tract that is often referred to as "the second brain", shares many features with the central nervous system. The ENS plays an essential role in regulating many GI functions including motility and fluid secretion. Enteric neuronal degeneration could therefore be responsible for the GI symptoms commonly observed in neurological conditions. Here we describe the organization and functions of the ENS and then review the evidence for ENS involvement in two common neurodegenerative disorders, Parkinson's disease (PD) and Alzheimer's disease (AD). Data from patients as well as animal models suggest that PD affects distinct subsets of neurons and glia in the ENS, and that the ENS may participate in the pathogenesis of this disorder. While there has been great enthusiasm for the possibility of sampling the ENS for diagnosis or therapeutic monitoring of PD, further work is needed to determine which enteric neurons are most affected and how ENS function could be modulated to ameliorate GI symptoms in patients. Although AD is far more common than PD and AD patients also experience GI symptoms, understanding of ENS dysfunction in AD is in its infancy. Much work remains to be done in both of these fields to determine how the ENS contributes to and/or is altered by these disorders, and how to target the ENS for more effective treatment of GI comorbidities.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Enteric nervous system; Neurodegeneration; Parkinson’s disease

Mesh:

Year:  2018        PMID: 29360466      PMCID: PMC6003851          DOI: 10.1016/j.brainres.2018.01.011

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  45 in total

1.  Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses.

Authors:  K Wakabayashi; H Takahashi; S Takeda; E Ohama; F Ikuta
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

2.  The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited.

Authors:  K Nakamura; V P Bindokas; J D Marks; D A Wright; D M Frim; R J Miller; U J Kang
Journal:  Mol Pharmacol       Date:  2000-08       Impact factor: 4.436

3.  Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus.

Authors:  Hong Can Zhu; Jing Zhao; Chang Yue Luo; Qian Qian Li
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

4.  Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism.

Authors:  T Chaumette; T Lebouvier; P Aubert; B Lardeux; C Qin; Q Li; D Accary; E Bézard; S Bruley des Varannes; P Derkinderen; M Neunlist
Journal:  Neurogastroenterol Motil       Date:  2008-12-05       Impact factor: 3.598

5.  Changes of the enteric nervous system in amyloid-β protein precursor transgenic mice correlate with disease progression.

Authors:  Sandra Semar; Markus Klotz; Maryse Letiembre; Chris Van Ginneken; Anne Braun; Viktor Jost; Michael Bischof; Wim J Lammers; Yang Liu; Klaus Fassbender; Tony Wyss-Coray; Frank Kirchhoff; Karl-Herbert Schäfer
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein.

Authors:  Lixin Wang; Sheila M Fleming; Marie-Françoise Chesselet; Yvette Taché
Journal:  Neuroreport       Date:  2008-05-28       Impact factor: 1.837

7.  Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation.

Authors:  C Singaram; W Ashraf; E A Gaumnitz; C Torbey; A Sengupta; R Pfeiffer; E M Quigley
Journal:  Lancet       Date:  1995-09-30       Impact factor: 79.321

Review 8.  Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update.

Authors:  Lars Brichta; Paul Greengard
Journal:  Front Neuroanat       Date:  2014-12-15       Impact factor: 3.856

9.  Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice.

Authors:  Francisco Pan-Montojo; Oleg Anichtchik; Yanina Dening; Lilla Knels; Stefan Pursche; Roland Jung; Sandra Jackson; Gabriele Gille; Maria Grazia Spillantini; Heinz Reichmann; Richard H W Funk
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

10.  Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice.

Authors:  Francisco Pan-Montojo; Mathias Schwarz; Clemens Winkler; Mike Arnhold; Gregory A O'Sullivan; Arun Pal; Jonas Said; Giovanni Marsico; Jean-Marc Verbavatz; Margarita Rodrigo-Angulo; Gabriele Gille; Richard H W Funk; Heinz Reichmann
Journal:  Sci Rep       Date:  2012-11-30       Impact factor: 4.379

View more
  35 in total

Review 1.  Disorders of the enteric nervous system - a holistic view.

Authors:  Beate Niesler; Stefanie Kuerten; I Ekin Demir; Karl-Herbert Schäfer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-01-29       Impact factor: 46.802

2.  Immunohistochemical expression and neurochemical phenotypes of huntingtin-associated protein 1 in the myenteric plexus of mouse gastrointestinal tract.

Authors:  Abu Md Mamun Tarif; Md Nabiul Islam; Mir Rubayet Jahan; Akie Yanai; Kanako Nozaki; Koh-Hei Masumoto; Koh Shinoda
Journal:  Cell Tissue Res       Date:  2021-10-19       Impact factor: 5.249

Review 3.  A Critical Analysis of Intestinal Enteric Neuron Loss and Constipation in Parkinson's Disease.

Authors:  Chelsea O'Day; David Isaac Finkelstein; Shanti Diwakarla; Rachel Mai McQuade
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 4.  Central and Peripheral Inflammation: Connecting the Immune Responses of Parkinson's Disease.

Authors:  Gregory P Williams; Aubrey M Schonhoff; Alessandro Sette; Cecilia S Lindestam Arlehamn
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 5.  Therapeutic Potential of Astrocyte Transplantation.

Authors:  Nataly Hastings; Wei-Li Kuan; Andrew Osborne; Mark R N Kotter
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

6.  Optogenetic activation of the distal colon epithelium engages enteric nervous system circuits to initiate motility patterns.

Authors:  Sarah A Najjar; Brian S Edwards; Kathryn M Albers; Brian M Davis; Kristen M Smith-Edwards
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-09-01       Impact factor: 4.871

7.  Robust, 3-Dimensional Visualization of Human Colon Enteric Nervous System Without Tissue Sectioning.

Authors:  Kahleb D Graham; Silvia Huerta López; Rajarshi Sengupta; Archana Shenoy; Sabine Schneider; Christina M Wright; Michael Feldman; Emma Furth; Federico Valdivieso; Amanda Lemke; Benjamin J Wilkins; Ali Naji; Edward J Doolin; Marthe J Howard; Robert O Heuckeroth
Journal:  Gastroenterology       Date:  2020-02-27       Impact factor: 22.682

8.  High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors.

Authors:  Luisa Seguella; Mirella Pesce; Riccardo Capuano; Fabrizio Casano; Marcella Pesce; Chiara Corpetti; Martina Vincenzi; Daniela Maftei; Roberta Lattanzi; Alessandro Del Re; Giovanni Sarnelli; Brian D Gulbransen; Giuseppe Esposito
Journal:  J Neuroinflammation       Date:  2021-05-16       Impact factor: 8.322

Review 9.  Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders.

Authors:  Yijing Chen; Jinying Xu; Yu Chen
Journal:  Nutrients       Date:  2021-06-19       Impact factor: 5.717

10.  Cerebral dopamine neurotrophic factor is essential for enteric neuronal development, maintenance, and regulation of gastrointestinal transit.

Authors:  Alcmène Chalazonitis; ZhiShan Li; Tuan D Pham; Jason Chen; Meenakshi Rao; Päivi Lindholm; Mart Saarma; Maria Lindahl; Michael D Gershon
Journal:  J Comp Neurol       Date:  2020-03-26       Impact factor: 3.028

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.